Figure 2.
InO induction followed by standard chemotherapy yields high remission rates and promising survival in older (>55 years) patients with de novo B-lymphoblastic leukemia (GMALL-Initial-1 trial). Survival outcome with confidence intervals. Reproduced from Stelljes et al40 with permission.

InO induction followed by standard chemotherapy yields high remission rates and promising survival in older (>55 years) patients with de novo B-lymphoblastic leukemia (GMALL-Initial-1 trial). Survival outcome with confidence intervals. Reproduced from Stelljes et al40 with permission.

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal